Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain

[1]  J. Woodgett,et al.  The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease , 2002, Acta Neuropathologica.

[2]  C. C. Wong,et al.  Effects of neonatal hypothyroidism on the expressions of growth cone proteins and axon guidance molecules related genes in the hippocampus , 2001, Molecular and Cellular Endocrinology.

[3]  P. Cohen,et al.  GSK3 takes centre stage more than 20 years after its discovery. , 2001, The Biochemical journal.

[4]  James R. Woodgett,et al.  Judging a Protein by More Than Its Name: GSK-3 , 2001, Science's STKE.

[5]  A. Harwood,et al.  Regulation of GSK-3 A Cellular Multiprocessor , 2001, Cell.

[6]  M. Mercken,et al.  Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[7]  S. Vijayaraghavan,et al.  A Role for Phosphorylation of Glycogen Synthase Kinase-3α in Bovine Sperm Motility Regulation1 , 2000, Biology of reproduction.

[8]  K. Ishiguro,et al.  Distribution of tau protein kinase I/glycogen synthase kinase-3β, phosphatases 2A and 2B, and phosphorylated tau in the developing rat brain , 2000, Brain Research.

[9]  P. Shaw,et al.  Expression analysis of glycogen synthase kinase-3 in human tissues. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[10]  J. Brion,et al.  Developmental expression and localization of glycogen synthase kinase-3β in rat brain , 1999, Journal of Chemical Neuroanatomy.

[11]  M. Waye,et al.  Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. , 1998, Genome.

[12]  K. Imahori,et al.  Possible Role of Tau Protein Kinases in Pathogenesis of Alzheimer’s Disease , 1998, Neurobiology of Aging.

[13]  A. M. Møller,et al.  Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3α and β isoforms in patients with NIDDM , 1997, Diabetologia.

[14]  X Wang,et al.  Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3‐kinase , 1997, FEBS letters.

[15]  Christoph W. Turck,et al.  Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3 , 1997, Science.

[16]  K. Imahori,et al.  Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. , 1997, Journal of biochemistry.

[17]  E. Braak,et al.  Distribution, Levels, and Activity of Glycogen Synthase Kinase‐3 in the Alzheimer Disease Brain , 1997, Journal of neuropathology and experimental neurology.

[18]  K. Imahori,et al.  Immunocytochemistry of tau phosphoserine 413 and tau protein kinase I in Alzheimer pathology , 1996, Brain Research.

[19]  K. Imahori,et al.  Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II , 1996, Acta Neuropathologica.

[20]  R. Atkins,et al.  A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[21]  S. Lovestone,et al.  Modulation of PHF-like tau phosphorylation in cultured neurones and transfected cells , 1995, Neurobiology of Aging.

[22]  Harold E. Varmus,et al.  Glycogen synthase kinase-3 and dorsoventral patterning in Xenopus embryos , 1995, Nature.

[23]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[24]  J. Woodgett,et al.  PHF‐tau from Alzheimer's brain comprises four species on SDS‐PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase‐3β , 1994, FEBS letters.

[25]  J. Woodgett.  Regulation and functions of the glycogen synthase kinase-3 subfamily. , 1994, Seminars in cancer biology.

[26]  K. Imahori,et al.  Localization and Developmental Changes of τ Protein Kinase I/Glycogen Synthase Kinase‐3β in Rat Brain , 1994 .

[27]  J. Woodgett,et al.  Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. , 1994, Oncogene.

[28]  G. Klein,et al.  Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. , 1993, Oncogene.

[29]  V. Pantesco,et al.  Drosophila shaggy kinase and rat glycogen synthase kinase-3 have conserved activities and act downstream of Notch , 1993, Nature.

[30]  J. Woodgett,et al.  Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells. , 1993, Oncogene.

[31]  J. Woodgett,et al.  Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. , 1992, Oncogene.

[32]  J. Woodgett,et al.  Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.

[33]  Y. Ihara,et al.  Phosphorylated tau protein is integrated into paired helical filaments in Alzheimer's disease. , 1986, Journal of biochemistry.

[34]  W. Benjamin,et al.  Cyclic nucleotide-independent protein kinase from rat liver. Purification and characterization of a multifunctional protein kinase. , 1985, The Journal of biological chemistry.

[35]  P. Cohen,et al.  Glycogen synthase kinase-3 from rabbit skeletal muscle. , 1981, Methods in enzymology.

[36]  P. Cohen,et al.  Purification of glycogen synthase kinase 3 from rabbit skeletal muscle. Copurification with the activating factor (FA) of the (Mg-ATP) dependent protein phosphatase. , 1981, European journal of biochemistry.